4//SEC Filing
Smith Karen L. 4
Accession 0001600620-24-000114
CIK 0001600620other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 7:20 PM ET
Size
8.8 KB
Accession
0001600620-24-000114
Insider Transaction Report
Form 4
Smith Karen L.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-11-08−17,913→ 0 total→ Common Stock (17,913 underlying) - Exercise/Conversion
Common Stock
2024-11-08+17,913→ 17,913 total - Sale
Common Stock
2024-11-11$8.43/sh−5,241$44,182→ 12,672 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
- [F3]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.37 to $8.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F4]The RSUs vested one year from date of grant and have no expiration date.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001639637
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 7:20 PM ET
- Size
- 8.8 KB